|
14 Mar 2025 |
ICICI Lombard
|
Consensus Share Price Target
|
1678.75 |
2158.11 |
- |
28.55 |
buy
|
|
|
|
|
31 Jan 2025
|
ICICI Lombard
|
Geojit BNP Paribas
|
1678.75
|
2030.00
|
1858.50
(-9.67%)
|
20.92 |
Hold
|
|
|
|
|
19 Jan 2025
|
ICICI Lombard
|
Emkay
|
1678.75
|
2000.00
|
1948.75
(-13.86%)
|
Target met |
Sell
|
|
|
ICICIGI reported a strong performance for Q3FY25, wherein GWP at Rs64.7bn (+0.6% YoY), impacted by the 1/n regulation, came in 0.9% lower than our estimate; however, combined ratio at 102.7% was significantly lower than our estimate of 103.9%, driving PAT of Rs7.2bn (+68% YoY) and beating our estimate by 12.4%.
|
|
17 Jan 2025
|
ICICI Lombard
|
Motilal Oswal
|
1678.75
|
2300.00
|
1948.75
(-13.86%)
|
37.01 |
Buy
|
|
|
ICICIGI’s gross domestic premium income (GDPI) was flat YoY in 3QFY25 at INR65b (in line), impacted by 1/n regulation implementation for longterm products.
|
|
17 Jan 2025
|
ICICI Lombard
|
Sharekhan
|
1678.75
|
2550.00
|
1948.75
(-13.86%)
|
51.90 |
Buy
|
|
|
In Q3FY25, ICICI Lombard’s PAT beat estimates at Rs. 724 crore, rising 68% y-o-y. Higher investment income (up 28% y-o-y) and lower claims ratio (in motor & commercial lines) drove strong earnings.
|
|
23 Oct 2024
|
ICICI Lombard
|
ICICI Direct
|
1678.75
|
2100.00
|
1958.95
(-14.30%)
|
25.09 |
Hold
|
|
|
|
|
20 Oct 2024
|
ICICI Lombard
|
Emkay
|
1678.75
|
1900.00
|
2020.95
(-16.93%)
|
Target met |
Sell
|
|
|
ICICIGI reported a mixed Q2FY25 result, where the operating performance at 10.8% YoY GWP growth and the combined ratio at 104.5% came in lower than our estimates.
|
|
18 Oct 2024
|
ICICI Lombard
|
Motilal Oswal
|
1678.75
|
2400.00
|
2020.95
(-16.93%)
|
42.96 |
Buy
|
|
|
ICICIGI’s GDP grew 11% YoY in 2QFY25 to INR69b (3% miss). NEP grew 17% YoY to INR50b (3% ahead of our estimates).
|
|
23 Sep 2024
|
ICICI Lombard
|
Motilal Oswal
|
1678.75
|
2650.00
|
2275.20
(-26.22%)
|
57.86 |
Buy
|
|
|
ICICI Lombard (ICICIGI) has experienced improved market share across segments on a YTD basis, most notably in the Motor OD, Motor TP, and Health segments by 179/83/85bp.
|
|
23 Aug 2024
|
ICICI Lombard
|
Sharekhan
|
1678.75
|
2550.00
|
2096.80
(-19.94%)
|
51.90 |
Buy
|
|
|
ICICI Lombard remains confident of a continued growth trajectory led by the motor and health segments.
|
|
23 Aug 2024
|
ICICI Lombard
|
IDBI Capital
|
1678.75
|
|
2096.80
(-19.94%)
|
|
Strategy Note
|
|
|
|
|
01 Aug 2024
|
ICICI Lombard
|
Geojit BNP Paribas
|
1678.75
|
2331.00
|
2004.35
(-16.24%)
|
38.85 |
Buy
|
|
|
|
|
22 Jul 2024
|
ICICI Lombard
|
ICICI Direct
|
1678.75
|
2050.00
|
1896.30
(-11.47%)
|
Target met |
Hold
|
|
|
|
|
22 Jul 2024
|
ICICI Lombard
|
ICICI Direct
|
1678.75
|
2050.00
|
1896.30
(-11.47%)
|
Target met |
Hold
|
|
|
|
|
14 Jun 2024
|
ICICI Lombard
|
IDBI Capital
|
1678.75
|
2100.00
|
1730.90
(-3.01%)
|
Target met |
Buy
|
|
|
|
|
14 Jun 2024
|
ICICI Lombard
|
Motilal Oswal
|
1678.75
|
2100.00
|
1730.90
(-3.01%)
|
Target met |
Buy
|
|
|
ICICI Lombard (ICICIGI), through its annual report, has reiterated its future readiness to capitalize on this fast-growing general insurance industry.
|
|
06 May 2024
|
ICICI Lombard
|
Geojit BNP Paribas
|
1678.75
|
1898.00
|
1681.35
(-0.15%)
|
Target met |
Buy
|
|
|
|
|
17 Apr 2024
|
ICICI Lombard
|
Sharekhan
|
1678.75
|
1950.00
|
1710.10
(-1.83%)
|
Target met |
Buy
|
|
|
|
|
01 Apr 2024
|
ICICI Lombard
|
Sharekhan
|
1678.75
|
1950.00
|
1688.90
(-0.60%)
|
Target met |
Buy
|
|
|
|
|
17 Jan 2024
|
ICICI Lombard
|
Sharekhan
|
1678.75
|
1740.00
|
1440.05
(16.58%)
|
Target met |
Buy
|
|
|
|
|
16 Jan 2024
|
ICICI Lombard
|
Motilal Oswal
|
1678.75
|
1650.00
|
1374.20
(22.16%)
|
Target met |
Buy
|
|
|
|